ZYFLO CR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zyflo Cr, and what generic alternatives are available?
Zyflo Cr is a drug marketed by Chiesi and is included in one NDA.
The generic ingredient in ZYFLO CR is zileuton. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the zileuton profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zyflo Cr
A generic version of ZYFLO CR was approved as zileuton by RISING on March 17th, 2017.
Summary for ZYFLO CR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZYFLO CR |
DailyMed Link: | ZYFLO CR at DailyMed |
US Patents and Regulatory Information for ZYFLO CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZYFLO CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZYFLO CR
See the table below for patents covering ZYFLO CR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2099079 | ⤷ Try a Trial | |
European Patent Office | 0416609 | Composés inhibiteurs de lipoxygénase dérivés du benzo[b]thiophène (Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds) | ⤷ Try a Trial |
Canada | 2145513 | COMPRIME POUVANT LIBERER A DIFFERENTES VITESSES UN OU PLUSIEURS MEDICAMENTS (PHARMACEUTICAL TABLET CAPABLE OF LIBERATING ONE OR MORE DRUGS AT DIFFERENT RELEASE RATES) | ⤷ Try a Trial |
Austria | 135906 | ⤷ Try a Trial | |
Australia | 631244 | ⤷ Try a Trial | |
South Korea | 960004865 | ⤷ Try a Trial | |
Australia | 6220190 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |